Dr. Herman is a 2015 “New York Super Doctor.” No more than 5% of physicians in the New York metro region achieve this designation, which is given by Key Professional Media, a leading research and medical ranking organization.

1. News From:
For Immediate Release September 14, 2015
Contact: Damian Becker, Manager of Media Relations
(516) 377-5370
Urologic Cancer “Super Doc” Joins
South Nassau’s Medical Staff
Oceanside, NY — Noted urologic cancer specialist and researcher Michael Herman, M.D., has
joined South Nassau Communities Hospital’s medical staff as director of urologic oncology.
“Dr. Herman is in the forefront of the treatment and research of urologic cancers,” said Rajiv
Datta, MD, chair of the department of surgery and medical director of the Gertrude & Louis Feil Cancer
Center at South Nassau Communities Hospital. “His experience and expertise in using leading-edge
medical technologies and therapies to treat urologic cancers, including prostate cancer, will be a benefit
to the communities and patients served by South Nassau.”
Prior to coming to South Nassau, Dr. Herman served as Assistant Professor in the Department of
Urology at Weill Cornell Medical Center and an Assistant Attending at New York-Presbytherian
Hospital. Dr. Herman earned his MD at the University of Texas Southwestern Medical Center and
completed his residency at Weill Cornell Medical College. During his residency, Dr. Herman won
Physician of the Year, New York-Presbyterian Hospital (2008), First place for AUA/Gyrus Prize Essay
Contest (2009), and the Distinguished Housestaff Award, New York-Presbyterian Hospital (2010).
Dr. Herman is a 2015 “New York Super Doctor.” No more than 5% of physicians in the New
York metro region achieve this designation, which is given by Key Professional Media, a leading
research and medical ranking organization. According to Key Professional Media, in selecting
physicians for Super Doctors, the publisher employs a rigorous multi-step process designed to identify
physicians who have attained a high degree of peer recognition and professional achievement. Super
Doctors is a selective yet diverse listing of outstanding physicians, representing consumer-oriented
medical specialties.
Dr. Herman received research support from the National Institutes of Health as a co-investigator
exploring the application of multiphoton microscopy in prostate cancer, an advanced imaging technique
to improve prostate cancer detection. He also maintains an active presence as a reviewer for multiple top
urology journals.

2. A co-author of three book chapters and more than 30 peer-reviewed journal articles, as well as
dozens of abstracts, Dr. Herman continues to be involved in the front line of urologic oncology. His
current interests include reducing the over diagnosis and overtreatment of prostate cancer by using the
latest biomarkers and imaging techniques. This can reduce the number of unnecessary biopsies while
more accurately diagnosing aggressive prostate cancer, thereby leading to improved outcomes for
patients. He utilizes novel genetic testing to see who is a good candidate for active surveillance, or
monitoring, of their cancers. Finally, he focuses on minimally invasive treatments for prostate, kidney,
and bladder cancers, including robotic and laparoscopic surgery. Dr. Herman is interested in facilitating
clinical and collaborative research at South Nassau. To schedule a consultation with Dr. Herman, call
the Gertrude & Louis Feil Cancer Center, (516) 632-3330.
South Nassau is a recipient of the American Heart Association/American Stroke Association’s
Get With The Guidelines®–Target: Stroke Honor Roll-Elite Quality Achievement Award as well as the
American Heart Association/American College of Cardiology Foundation Get With The Guidelines®–
Heart Failure Silver-Plus Quality Achievement Award.
Designated a Magnet® hospital by the American Nurses Credentialing Center (ANCC), South
Nassau® Communities Hospital is one of the region’s largest hospitals, with 455 beds, more than 900
physicians and 3,000 employees. Located in Oceanside, NY, the hospital is an acute-care, not-for-profit
teaching hospital that provides state-of-the-art care in cardiac, oncologic, orthopedic, bariatric, pain
management, mental health and emergency services. In addition to its extensive outpatient specialty
centers, South Nassau provides emergency and elective angioplasty, and is the only hospital on Long
Island with the Novalis Tx™ and Gamma Knife® radiosurgery technologies. South Nassau is a
designated Stroke Center by the New York State Department of Health and Comprehensive Community
Cancer Center by the American College of Surgeons and is an accredited center of the Metabolic and
Bariatric Surgery Association and Quality Improvement Program. In addition, the hospital has been
awarded the Joint Commission’s gold seal of approval as a Top Performer on Key Quality Measures,
including heart attack, heart failure, pneumonia and surgical care; and disease-specific care for hip and
joint replacement, wound care and end-stage renal disease. For more information, visit
www.southnassau.org.
-30-